Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1988;95(2):171-5.
doi: 10.1007/BF00174504.

Intravenous nicotine in Alzheimer's disease: a pilot study

P A Newhouse  1 , T Sunderland, P N Tariot, C L Blumhardt, H Weingartner, A Mellow, D L Murphy
Affiliations
Clinical Trial

Intravenous nicotine in Alzheimer's disease: a pilot study

P A Newhouse et al. Psychopharmacology (Berl). 1988.

Abstract

In the first study to examine direct nicotinic augmentation of central cholinergic functioning in Alzheimer's disease, six patients were studied in an intensive pilot study with three doses (0.125, 0.25, and 0.5 microgram/kg/min) of intravenous nicotine and placebo. Cognitive tests showed a decrease in intrusion errors on the middle (0.25 microgram) dose. Prominent behavioral effects were noted, with significant dose-related increases in anxiety and depressive affect. These results suggest that central nicotinic cholinergic stimulation deserves further investigation as a treatment in Alzheimer's disease and that nicotine may also be a useful investigative tool in other populations as a probe of central cholinergic function, especially in regard to the modulation of affect.

PubMed Disclaimer

References

    1. Science. 1983 Mar 11;219(4589):1184-90 - PubMed
    1. J Am Geriatr Soc. 1985 Nov;33(11):749-57 - PubMed
    1. Psychopharmacology (Berl). 1984;84(1):5-11 - PubMed
    1. Psychopharmacology (Berl). 1985;86(3):245-52 - PubMed
    1. Am J Psychiatry. 1982 Sep;139(9):1136-9 - PubMed

Publication types

LinkOut - more resources